medigraphic.com
ISSN 1405-1699 (Print)
Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría

2022, Number 3

<< Back Next >>

Alerg Asma Inmunol Pediatr 2022; 31 (3)

Latex allergy

Arce-Estrada GE, Arce-Estrada J, Contreras-Verduzco FA, García-Hernández XM, Aguilar-Ramos CI, Espinosa-Padilla SE

Language: Spanish
References: 40
Page: 74-83
PDF size: 256.09 Kb.


ABSTRACT

Latex is the material obtained from the milky sap, synthesized by specialized laticiferous cells, and from the damaged bark of the Hevea brasiliensis tree. The allergens Hev b1, Hev b3, Hev b5 and Hev b6.02 are considered genuine major allergens, useful indicators for diagnostic tests. Latex allergy is an immediate hypersensitivity reaction, caused by previous exposure to products containing latex proteins and is triggered in people with specific IgE for this material and where some cells are also involved. Latex-fruit syndrome is a clinical association between latex allergy and an allergic response to certain fruits and/or vegetables. The main strategy for treatment is avoidance, the second step of treatment is the use of antihistamines and steroids to reduce clinical manifestations.


REFERENCES

  1. Sociedad Española de Inmunología Clínica, Alergología y Asma Pediátrica [Internet]. Disponible en: https://seicap.es/

  2. Kleine-Tebbe J, Jakob T. Molecular allergy diagnostics using IgE singleplex determinations: methodological and practical considerations for use in clinical routine: part 18 of the series molecular allergology. Allergo J Int. 2015; 24: 185-197. doi: 10.1007/s40629-015-0067-z.

  3. NaturaLista México [Internet]. NaturaLista México. Disponible en: https://www.naturalista.mx/

  4. Raulf M. Current state of occupational latex allergy. Curr Opin Allergy Clin Immunol. 2020; 20 (2): 112-116. doi: 10.1097/ACI.0000000000000611.

  5. Arroyo-Cruz ME, Collado-Chagoya R, Hernández-Romero J, Eliosa Alvarado-Gumaro A, García-González AC, Campos-Gutiérrez RI et al. Sensibilización y alergia a látex en residentes quirúrgicos del Hospital General de México. Rev Alerg Mex. 2018; 65 (2): 128-139. doi: 10.29262/ram.v65i2.331.

  6. Kawai M, Kondo Y, Nakajima Y, Tsuge I, Yoshikawa T, Yagami A et al. Changes in the characteristics of patients with latex allergy from 1999 to 2014. Fujita Med J. 2020; 6 (3): 67-72. doi: 10.20407/fmj.2019-013.

  7. Nucera E, Aruanno A, Rizzi A, Centrone M. Latex allergy: current status and future perspectives. J Asthma Allergy. 2020; 13: 385-398. doi: 10.2147/JAA.S242058.

  8. Poley GE Jr, Slater JE. Latex allergy. J Allergy Clin Immunol. 2000; 105 (6 Pt 1): 1054-1062. doi: 10.1067/mai.2000.106925.

  9. Hosler D, Burkett SL, Tarkanian MJ. Prehistoric polymers: rubber processing in ancient Mesoamerica. Science. 1999; 284 (5422): 1988-1991. doi: 10.1126/science.284.5422.1988.

  10. Randers-Pehrson JD. The surgeon's glove. Springfield, Ill: Thomas; 1960. p. 95.

  11. Stern G. Überempfindlichkeit Gegen Kautschuk als Ursache von Urticaria und Quinckeschem odem. Klin Wochenschr. 1927; 6: 1096-1097. doi: 10.1007/BF01890315.

  12. Turjanmaa K, Reunala T, Tuimala R, Karkkainen T. Severe IgE mediated allergy to surgical gloves [abstract]. Allergy. 1984; 39: S2.

  13. Sutton MY, Jones RL, Wolitski RJ, Cleveland JC, Dean HD, Fenton KA. A review of the centers for disease control and prevention's response to the HIV/AIDS crisis among Blacks in the United States, 1981-2009. Am J Public Health. 2009; 99 Suppl 2 (Suppl 2): S351-S359. doi: 10.2105/AJPH.2008.157958.

  14. Slater JE. Rubber anaphylaxis. N Engl J Med. 1989; 320 (17): 1126-1130. doi: 10.1056/NEJM198904273201707.

  15. Gerber AC, Jorg W, Zbinden S, Seger RA, Dangel PH. Severe intraoperative anaphylaxis to surgical gloves: latex allergy, an unfamiliar condition. Anesthesiology. 1989; 71 (5): 800-802. doi: 10.1097/00000542-198911000-00031.

  16. Taylor JS, Cassettari J, Wagner W, Helm T. Contact urticaria and anaphylaxis to latex. J Am Acad Dermatol. 1989; 21 (4 Pt 2): 874-877. doi: 10.1016/s0190-9622(89)70271-1.

  17. Morales C, Basomba A, Carreira J, Sastre A. Anaphylaxis produced by rubber glove contact. Case reports and immunological identification of the antigens involved. Clin Exp Allergy. 1989; 19 (4): 425-430. doi: 10.1111/j.1365-2222.1989.tb02409.x.

  18. Turjanmaa K, Reunala T. Condoms as a source of latex allergen and cause of contact urticaria. Contact Dermatitis. 1989; 20 (5): 360-364. doi: 10.1111/j.1600-0536.1989.tb03173.x.

  19. Spaner D, Dolovich J, Tarlo S, Sussman G, Buttoo K. Hypersensitivity to natural latex. J Allergy Clin Immunol. 1989; 83 (6): 1135-1137. doi: 10.1016/0091-6749(89)90457-0.

  20. Leynadier F, Pecquet C, Dry J. Anaphylaxis to latex during surgery. Anaesthesia. 1989; 44 (7): 547-550. doi: 10.1111/j.1365-2044.1989.tb11438.x.

  21. Ebied AM, Cooper-DeHoff RM. 2017 is banner year for drug approvals by the food and drug administration. Am J Med. 2018; 131 (9): 1025-1033. doi: 10.1016/j.amjmed.2018.02.034.

  22. Macías-Robles AP, Morán-Mendoza AR. Prevalencia de sensibilización al látex mediante prueba cutánea (prick test) en pacientes con malformaciones genitourinarias con más de tres intervenciones quirúrgicas. Rev Alerg Mex. 2016; 63 (2): 154-162. doi: 10.29262/ram.v63i2.140.

  23. Suli C, Parziale M, Lorini M, De Silva E, Miadonna A, Tedeschi A. Prevalence and risk factors for latex allergy: a cross sectional study on health-care workers of an Italian hospital. J Investig Allergol Clin Immunol. 2004; 14 (1): 64-69.

  24. Lieberman P. Anaphylactic reactions during surgical and medical procedures. J Allergy Clin Immunol. 2002; 110 (2 Suppl): S64-S69. doi: 10.1067/mai.2002.124970.

  25. Kannan JA, Bernstein JA. Perioperative anaphylaxis: diagnosis, evaluation, and management. Immunol Allergy Clin North Am. 2015; 35 (2): 321-334. doi: 10.1016/j.iac.2015.01.002.

  26. Bedolla-Barajas M, Macriz-Romero N, Jara-Ettinger AC, Macriz-Romero M, Fregoso-Fregoso M, Morales-Romero J. Autorreporte de alergia al látex en estudiantes de medicina: prevalencia y factores asociados. Rev Alerg Mex. 2018; 65 (1): 10-18. doi: 10.29262/ram.v65i1.290.

  27. Matricardi PM, Kleine-Tebbe J, Hoffmann HJ, Valenta R, Hilger C, Hofmaier S et al. EAACI molecular allergology user's guide. Pediatr Allergy Immunol. 2016; 27 Suppl 23: 1-250. doi: 10.1111/pai.12563.

  28. Kelly KJ, Sussman G. Latex allergy: where are we now and how did we get there? J Allergy Clin Immunol Pract. 2017; 5 (5): 1212-1216. doi: 10.1016/j.jaip.2017.05.029.

  29. Chong Quero LE, Orozco Martínez S, Huerta López JG. Alergia al látex. Alergia Asma Inmunol Pediatr. 2004; 13 (2): 44-52.

  30. Vandenplas O, Froidure A, Meurer U, Rihs HP, Rifflart C, Soetaert S et al. The role of allergen components for the diagnosis of latex-induced occupational asthma. Allergy. 2016; 71 (6): 840-849. doi: 10.1111/all.12872.

  31. Rodríguez GM, Mendoza HDA, Pedroza MA, Orozco MMS. Características clínicas de pacientes pediátricos con alergia a látex. Alerg Asma Inmunol Pediatr. 2017; 26 (2): 41-44.

  32. ACAAI Public Website [Internet]. American College of Allergy Asthma and Immunology | ACAAI Patient. Available in: https://acaai.org/

  33. Allergy & Asthma Network [Internet]. Latex Allergy and Foods | Allergy & Asthma Network. Available in: https://allergyasthmanetwork.org/allergies/latex-allergy/latex-allergy-foods/

  34. Sussman G, Gold M. Guidelines for the management of latex allergies and safe latex use in health care facilities. Arlington Heights, IL: Am College of Allergy Asthma and Immunology; 1996. www.acaai.org/public/physicians/latex.htm.

  35. Fundación BBVA. Impulso a la investigación y a las actividades culturales [Internet]. La alergia al látex. Libro de las enfermedades alérgicas de la Fundación BBVA. Disponible en: https://www.fbbva.es/alergia/otras-enfermedades-alergicas/alergia-al-latex/

  36. Servicio Andaluz de Salud [Internet]. Página inicial | Servicio Andaluz de Salud - Junta de Andalucía. Disponible en: https://www.sspa.juntadeandalucia.es/servicioandaluzdesalud/

  37. Nucera E, Mezzacappa S, Buonomo A, Centrone M, Rizzi A, Manicone PF et al. Latex immunotherapy: evidence of effectiveness. Postepy Dermatol Alergol. 2018; 35 (2): 145-150. doi: 10.5114/ada.2018.75235.

  38. Dantzer JA, Wood RA. The use of omalizumab in allergen immunotherapy. Clin Exp Allergy. 2018; 48 (3): 232-240. doi: 10.1111/cea.13084.

  39. Aruanno A, Chini R, Nucera E. Efficacy of omalizumab in reducing latex allergy. Postepy Dermatol Alergol. 2021; 38 (5): 921-923. doi: 10.5114/ada.2021.110072.

  40. Leynadier F, Doudou O, Gaouar H, Le Gros V, Bourdeix I, Guyomarch-Cocco L et al. Effect of omalizumab in health care workers with occupational latex allergy. J Allergy Clin Immunol. 2004; 113 (2): 360-361. doi: 10.1016/j.jaci.2003.11.020.




2020     |     www.medigraphic.com